Maraviroc as GVHD Prophylaxis in Transplant Recipients

Clinical trial NCT02167451 · TERMINATED

Trial details

NCT number: NCT02167451
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diagnoses That Require Stem Cell Transplant Graft Versus Host Disease (GVHD)

Start date: 2014-07-01
Primary completion: 2018-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.